Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Authors

Lindsey M. Hoffman
Maryam Fouladi
James Olson
Vinay M Daryani
Clinton F. StewartFollow
Cynthia Wetmore
Mehmet Kocak
Arzu Onar-Thomas
Lars Wagner
Sridharan Gururangan
Roger J. Packer, George Washington UniversityFollow
Susan M Blaney
Amar Gajjar
Larry E. Kun
James M. Boyett
Richard J. Gilbertson

Document Type

Journal Article

Publication Date

5-2015

Journal

Child's Nervous System

Volume

31

Issue

8

Inclusive Pages

1283-1289

DOI

10.1007/s00381-015-2725-3

APA Citation

Hoffman, L. M., Fouladi, M., Olson, J., Daryani, V. M., et al. (2015). Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: A pediatric brain tumor consortium study. Child's Nervous System, 31(8), 1283-1289.

Peer Reviewed

1